Advertisement

Topics

Ecstasy to treat PTSD by 2021? US FDA approves Ph III trial

08:56 EST 1 Dec 2016 | in-PharmaTechnologis

Party drug MDMA has been claimed to be effective in helping treat Post-traumatic stress disorder (PTSD) patients, with the FDA approving for a Ph III trial to go ahead in the US.

Original Article: Ecstasy to treat PTSD by 2021? US FDA approves Ph III trial

NEXT ARTICLE

More From BioPortfolio on "Ecstasy to treat PTSD by 2021? US FDA approves Ph III trial"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

Stress
Stress is caused by your perception of situations around you and then the reaction of your body to them. The automatic stress response to unexpected events is known as 'fight or flight'. Discovered by Walter Cannon in 1932, it is the release of h...